• No results found

University of Groningen Exploring new molecular imaging concepts of prostate cancer Wondergem, Maurits

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Exploring new molecular imaging concepts of prostate cancer Wondergem, Maurits"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Exploring new molecular imaging concepts of prostate cancer

Wondergem, Maurits

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Wondergem, M. (2017). Exploring new molecular imaging concepts of prostate cancer. University of

Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 1PDF page: 1PDF page: 1PDF page: 1

Exploring new Molecular Imaging

concepts of Prostate Cancer

(3)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 2PDF page: 2PDF page: 2PDF page: 2 Exploring new Molecular Imaging concepts of Prostate Cancer

PhD thesis, University of Groningen – with a summary in Dutch © M. Wondergem, Amsterdam, 2017

M.Wondergem@NWZ.nl

All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means without permission in writing from the author. The copyright of the articles that have been published or have been accepted for publication has been transferred to the respective journals.

ISBN: 978-94-034-0160-7

Cover design: Wondergem&Wondergem

Lay-out: Tara Kinneging, PersoonlijkProefschrift.nl Printing: Ipskamp Printing, www.proefschriften.net

(4)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 3PDF page: 3PDF page: 3PDF page: 3

Exploring new Molecular Imaging

concepts of Prostate Cancer

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

maandag 20 november 2017 om 16.15 uur

door

Maurits Wondergem

geboren op 8 oktober 1982

te Mariekerke

(5)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 4PDF page: 4PDF page: 4PDF page: 4

Promotores

Prof. dr. I.J. de Jong

Prof. dr. J. Pruim

Copromotor

Dr. F.M. van der Zant

Beoordelingscommissie

Prof. dr. R.A.J.O. Dierckx

Prof. dr. R.J.A. van Moorselaar

Prof. dr. A. Chiti

(6)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 5PDF page: 5PDF page: 5PDF page: 5 Voor mijn moeder en vader

(7)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 6PDF page: 6PDF page: 6PDF page: 6

CONTENTS

Chapter 1 Introduction and outline 11

Chapter 2 A literature review of 18F-sodiumfluoride PET/CT and 33 18F-choline or 11C-choline PET/CT for detection of bone

metastases in patients with prostate cancer

Maurits Wondergem, Friso M. van der Zant, Tjeerd van der Ploeg, Remco J.J. Knol

Nucl Med Comm. 2013; 34: 935

Chapter 3 99mTc-HDP Bone scintigraphy and 18F-sodiumfluoride 59

PET/CT in primary staging of patients with prostate cancer

Maurits Wondergem, Friso M. van der Zant, Remco J.J. Knol, Anne Marij G. Burgers, Siebe D. Bos, Igle J. de Jong, Jan Pruim

Submitted

Chapter 4 Kinetic study of 18F-fluorocholine uptake to differentiate 77

malignant and physiologic uptake of 18F-fluorocholine in

prostate cancer metastases

Maurits Wondergem, Remco J.J. Knol, Friso M. van der Zant, Tjeerd van der Ploeg, Jan Pruim, Igle J. de Jong

Submitted

Chapter 5 Impact of fasting on 18F-fluorocholine gastrointestinal 101

uptake and detection of lymph node metastases in patients with prostate cancer

Maurits Wondergem, Friso M. van der Zant, Remco J.J. Knol, Jan Pruim, Igle J. de Jong

EJNMMI Res. 2016; 6: 2

Chapter 6 Focal 18F-fluorocholine uptake on early dynamic PET/CT 113

imaging of the prostatic region; What does it mean?

Maurits Wondergem, Friso M. van der Zant, Remco J.J. Knol, Jan Pruim, Igle J. de Jong

Submitted

Chapter 7 18F-DCFPyL PET/CT in the detection of prostate cancer 131

at 60 and 120 minutes; detection rate, image quality, activity kinetics and biodistribution

Maurits Wondergem, Friso M. van der Zant, Remco J.J. Knol, Sergiy V. Lazarenko, Jan Pruim, Igle J. de Jong

(8)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 7PDF page: 7PDF page: 7PDF page: 7 Intermezzo 1 High 18F-DCFPyL uptake in adrenal adenomas 155

Johannes G.K. Peper, Sandra Srbljin, Friso M. van der Zant, Remco J.J. Knol, Maurits Wondergem

Clin Nucl Med. Accepted for publication July 2017

Chapter 8 Conclusions and future perspectives 163

Chapter 9 Summary 175

Addenda Dutch summary – Nederlandse Samenvatting 192

List of abbreviations 198

List of publications 200

Acknowledgements – Dankwoord 202

Curriculum vitae 206

(9)

514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem 514137-L-bw-Wondergem Processed on: 27-9-2017 Processed on: 27-9-2017 Processed on: 27-9-2017

Processed on: 27-9-2017 PDF page: 8PDF page: 8PDF page: 8PDF page: 8

Referenties

GERELATEERDE DOCUMENTEN

(22) studied the added value of 18 F-fluorocholine PET/CT and NaF PET/CT in staging high-risk prostate cancers (PSA 20–99 ng/ml and/or Gleason 8–10 tumours) in 90 patients

For both cohorts the number of positive, negative and equivocal findings, calculated diagnostic performance of the imaging modality in terms of sensitivity and specificity, as well

On the static images, a significant higher 18 F-fluorocholine uptake was measured in malignant lymph nodes compared to normal lymph nodes, adipose tissue and muscle

Intestinal activity that possibly interferes with the detection of lymph node metastases is encountered in all prostate cancer patients receiving 18 F-fluorocholine

The number of patients for which a histological biopsy was present in this study is unclear and, to our opinion, a decreasing PSA below 0.1 ng/ml after salvage radiation therapy

A recent case report showed faint accumulation of 68 Ga PSMA HBED-CC in an adrenal adenoma (8), but there are no reports of adrenal masses with high uptake of PSMA ligands...

Although, especially according to the standards for reporting diagnostic accuracy studies (STARD 2015), the currently available evidence for use of PSMA targeted tracers instead

Additionally a second cohort, which included patients that received 18 F-fluorocholine PET/CT for primary staging, was studied to determine whether increased tracer uptake on